UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

The lancet HIV, 2015-12, Vol.2 (12), p.e520-e529

2015

Volltextzugriff (PDF)

Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review

Bulletin of the World Health Organization, 2013-05, Vol.91 (5), p.377-385

2013

Volltextzugriff (PDF)

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy

Frontiers in immunology, 2023-03, Vol.14, p.1123342-1123342

2023

Volltextzugriff (PDF)

Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015

PloS one, 2017-05, Vol.12 (5), p.e0177634-e0177634

2017

Volltextzugriff (PDF)

Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial

Trials, 2024-07, Vol.25 (1), p.485-12, Article 485

2024

Volltextzugriff (PDF)

Assessing understandings and perceptions of HIV cure among peer navigators and treatment officers in Australia

HIV research & clinical practice, 2024-03, Vol.25 (1), p.2330751

2024

Volltextzugriff (PDF)

Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review

PloS one, 2013-02, Vol.8 (2), p.e56047-e56047

2013

Volltextzugriff (PDF)

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

Trials, 2020-10, Vol.21 (1), p.847-3, Article 847

2020

Volltextzugriff (PDF)

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies

AIDS research and therapy, 2020-11, Vol.17 (1), p.65-65, Article 65

2020

Volltextzugriff (PDF)

Remdesivir for the Treatment of Covid-19 — Preliminary Report

The New England journal of medicine, 2020-09, Vol.383 (10), p.992-994

2020

Volltextzugriff (PDF)

Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care

PloS one, 2015-05, Vol.10 (5), p.e0127726-e0127726

2015

Volltextzugriff (PDF)

Monkeypox infection presenting as genital rash, Australia, May 2022

Euro surveillance : bulletin européen sur les maladies transmissibles, 2022-06, Vol.27 (22), p.1

2022

Volltextzugriff (PDF)

Successful expanded clinic network collaboration and patient tracing for retention in HIV care

AIDS research and therapy, 2022-12, Vol.19 (1), p.61-61, Article 61

2022

Volltextzugriff (PDF)

Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV

AIDS (London), 2023-07, Vol.37 (9), p.1345-1360

2023

Volltextzugriff (PDF)

Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial

Journal of Virus Eradication, 2023-09, Vol.9 (3), p.100345-100345, Article 100345

2023

Volltextzugriff (PDF)

How do we enhance protective immunity to COVID-19 in lung transplant recipients?

The European respiratory journal, 2023-01, Vol.61 (1), p.2201723

2023

Volltextzugriff (PDF)

Updated Australian guidance for health care providers about “undetectable = untransmittable” for HIV

Medical journal of Australia, 2021-09, Vol.215 (5), p.201-202.e1

2021

Volltextzugriff (PDF)

Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment

The American journal of medicine, 2021-03, Vol.134 (3), p.e220-e221

2021

Volltextzugriff (PDF)

Meningococcal Vaccine in Mali and Gambia

The New England journal of medicine, 2023-08, Vol.389 (6), p.577-578

2023

Volltextzugriff (PDF)

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

Journal of Virus Eradication, 2021-03, Vol.7 (1), p.100032-100032, Article 100032

2021

Volltextzugriff (PDF)

Bringing evidence from press release to the clinic in the era of COVID-19

Journal of antimicrobial chemotherapy, 2021-02, Vol.76 (3), p.547-549

2021

Volltextzugriff (PDF)

Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2015-11, Vol.61 (9), p.1453-1461

2015

Volltextzugriff (PDF)

Clinical trials of antiretroviral treatment interruption in HIV-infected individuals

AIDS (London), 2019-04, Vol.33 (5), p.773-791

2019

Volltextzugriff (PDF)

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design

The Journal of infectious diseases, 2022-08, Vol.226 (2), p.236-245

2022

Volltextzugriff (PDF)

Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies

AIDS research and human retroviruses, 2020-04, Vol.36 (4), p.260-267

2020

Volltextzugriff (PDF)

1 – 25 von 676

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(647)
Mit Volltextzugriff
(580)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review

Soluble immune checkpoints as correlates for HIV persistence and T cell function in people with HIV on antiretroviral therapy

Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015

Bringing optimised COVID-19 vaccine schedules to immunocompromised populations (BOOST-IC): study protocol for an adaptive randomised controlled clinical trial

Assessing understandings and perceptions of HIV cure among peer navigators and treatment officers in Australia

Effects of physical tracing on estimates of loss to follow-up, mortality and retention in low and middle income country antiretroviral therapy programs: a systematic review

An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

Acceptability, motivation and the prospect of cure for people living with HIV and their healthcare providers in HIV cure-focused treatment interruption studies

Remdesivir for the Treatment of Covid-19 — Preliminary Report

Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care

Monkeypox infection presenting as genital rash, Australia, May 2022

Successful expanded clinic network collaboration and patient tracing for retention in HIV care

Immunogenicity, effectiveness, and safety of SARS-CoV-2 vaccination in people with HIV

Effect of high dose vitamin D3 on the HIV-1 reservoir: A pilot randomised controlled trial

How do we enhance protective immunity to COVID-19 in lung transplant recipients?

Updated Australian guidance for health care providers about “undetectable = untransmittable” for HIV

Early Outpatient Treatment of SARS-CoV-2 (COVID-19): A Comment

Meningococcal Vaccine in Mali and Gambia

Interrupting antiretroviral therapy in HIV cure trials during COVID-19: Adaptation to low transmission settings

Bringing evidence from press release to the clinic in the era of COVID-19

Long-term Virological Outcomes of First-Line Antiretroviral Therapy for HIV-1 in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis

Clinical trials of antiretroviral treatment interruption in HIV-infected individuals

Balancing Statistical Power and Risk in HIV Cure Clinical Trial Design

Perspectives on Analytical Treatment Interruptions in People Living with HIV and Their Health Care Providers in the Landscape of HIV Cure-Focused Studies

Suchergebnisse filtern